Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Transplantation. 2017 Jan;101(1):182–190. doi: 10.1097/TP.0000000000001080

Figure 2. Quartiles of BNP and cTnI and adverse outcomes.

Figure 2

BNP and cTnI concentrations were stratified by quartiles and hazard ratios for individual adverse outcomes were calculated before (circles) and after (squares) adding the other biomarker to the model.